Zynex (ZYXI) Projected to Post Earnings on Thursday

Zynex (NASDAQ:ZYXI) is anticipated to announce its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of ($0.19) per share and revenue of $22.7130 million for the quarter. Parties may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, November 6, 2025 at 3:15 PM ET.

Zynex Trading Down 2.9%

Shares of ZYXI stock opened at $1.32 on Wednesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.62 and a quick ratio of 0.45. The stock has a 50 day simple moving average of $1.48 and a 200-day simple moving average of $1.95. The company has a market cap of $39.99 million, a price-to-earnings ratio of -1.40 and a beta of 1.10. Zynex has a 1-year low of $1.23 and a 1-year high of $9.33.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on ZYXI shares. Royal Bank Of Canada reduced their price objective on shares of Zynex from $4.00 to $3.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 15th. HC Wainwright downgraded shares of Zynex from a “buy” rating to a “neutral” rating in a research report on Friday, August 1st. Weiss Ratings reissued a “sell (d-)” rating on shares of Zynex in a report on Wednesday, October 8th. Finally, LADENBURG THALM/SH SH raised Zynex from a “neutral” rating to a “buy” rating and set a $3.70 target price for the company in a report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Zynex currently has a consensus rating of “Hold” and an average price target of $4.90.

Institutional Trading of Zynex

A number of hedge funds and other institutional investors have recently modified their holdings of ZYXI. Engineers Gate Manager LP acquired a new position in Zynex in the second quarter valued at $32,000. XTX Topco Ltd acquired a new position in Zynex in the second quarter valued at $47,000. Sender Co & Partners Inc. acquired a new stake in shares of Zynex in the 2nd quarter valued at about $67,000. Jane Street Group LLC boosted its position in shares of Zynex by 239.9% in the 1st quarter. Jane Street Group LLC now owns 53,377 shares of the company’s stock valued at $117,000 after purchasing an additional 37,673 shares during the period. Finally, Bridgeway Capital Management LLC acquired a new stake in shares of Zynex in the 2nd quarter valued at about $108,000. 29.68% of the stock is owned by institutional investors and hedge funds.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.